home / stock / mxct / mxct news

MXCT News and Press, MaxCyte Inc. From 02/05/24

Stock Information
Company Name: MaxCyte Inc.
Stock Symbol: MXCT
Market: NASDAQ
Menu
MXCT MXCT Quote MXCT Short MXCT News MXCT Articles MXCT Message Board
Get MXCT Alerts

News, Short Squeeze, Breakout and More Instantly...
MXCT - How to Take Advantage of moves in (MXCT)

2024-02-05 07:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MXCT - MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen's Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers

ROCKVILLE, Md. and ST. LOUIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: MXCT), a leading cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics...

MXCT - MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs

ROCKVILLE, Md., and SYDNEY, Australia, Jan. 23, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based th...

MXCT - EXTR, URBN and APPI are among after hour movers

2024-01-09 16:20:04 ET Gainers: WISeKey International  ( WKEY ) +14% . MaxCyte ( MXCT ) +8% . Humacyte. ( HUMA ) +8% . Agora ( API ) +6% . Urban Outfitters ( URBN ) +6% . Losers: Grifols ( GRFS ) -9% . Ex...
MXCT - COMM, NKTX and AVIR are among after hour movers

2024-01-08 16:53:20 ET Gainers: Universe Pharmaceuticals  ( UPC ) +13% . MaxCyte ( MXCT ) +12% . WISeKey International Holding  ( WKEY ) +8% . Alset Capital Acquisition  ( ACAX ) +7% . Atea Pharmaceuticals ( AVIR ) +...

MXCT - MaxCyte says Q4 revenue is expected to be between $15.5M and $15.7M

2024-01-08 16:36:57 ET More on MaxCyte MaxCyte May Benefit From Potential Gene Therapy Approval MaxCyte announces departure of founder and CEO Doug Doerfler Gene editing stocks mixed despite world’s first CRISPR drug approval Seeking Alpha’s Qua...

MXCT - MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results

ROCKVILLE, Md., Jan. 08, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioproce...
MXCT - MaxCyte and Lion TCR join hands for Lion TCR's global expansion

2024-01-03 10:22:28 ET More on MaxCyte MaxCyte May Benefit From Potential Gene Therapy Approval MaxCyte announces departure of founder and CEO Doug Doerfler Gene editing stocks mixed despite world’s first CRISPR drug approval For further details see: ...

MXCT - MaxCyte and Lion TCR form Partnership to Support Global Expansion of Lion TCR's TCR-T Cell Pipeline

ROCKVILLE, Md. and SINGAPORE, Jan. 03, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and ...

MXCT - MaxCyte gets new CEO and President

2024-01-02 05:27:10 ET More on MaxCyte MaxCyte May Benefit From Potential Gene Therapy Approval MaxCyte announces departure of founder and CEO Doug Doerfler Seeking Alpha’s Quant Rating on MaxCyte For further details see: MaxCyte gets new CEO and P...
Previous 10 Next 10